These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6150862)

  • 21. Vascular serotonin receptors. Correlation with 5-HT1 and 5-HT2 binding sites.
    Peroutka SJ
    Biochem Pharmacol; 1984 Aug; 33(15):2349-53. PubMed ID: 6380502
    [No Abstract]   [Full Text] [Related]  

  • 22. Net production of cerebrospinal fluid is decreased by SCH-23390.
    Boyson SJ; Alexander A
    Ann Neurol; 1990 Jun; 27(6):631-5. PubMed ID: 2193614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular smooth muscle serotonin and alpha-adrenoceptors.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1983; 10(3):265-7. PubMed ID: 6313264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
    Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
    Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
    Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
    J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
    Gredal O; Parkinson D; Nielsen M
    Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity.
    Alvarez-Guerra M; d'Alché-Birée F; Wolf WA; Vargas F; Dib M; Garay RP
    Psychopharmacology (Berl); 2000 Jan; 147(4):412-7. PubMed ID: 10672635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats.
    Nishimura Y
    Br J Pharmacol; 1996 Mar; 117(6):1325-1333. PubMed ID: 8882632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
    Choppin A; O'Connor SE
    Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy.
    Sumiyoshi T; Suzuki K; Sakamoto H; Yamaguchi N; Mori H; Shiba K; Yokogawa K
    Neuropsychopharmacology; 1995 Feb; 12(1):57-64. PubMed ID: 7766287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction.
    Conolan S; Taylor DA
    Eur J Pharmacol; 1986 Apr; 123(2):299-302. PubMed ID: 3709667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
    Ko FN; Yu SM; Su MJ; Wu YC; Teng CM
    Br J Pharmacol; 1993 Oct; 110(2):882-8. PubMed ID: 7902181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.